Skip to main content
Top
Published in: Trials 1/2017

Open Access 01-12-2017 | Erratum

Erratum to: Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial

Authors: Celine Busard, Stef Menting, SJ van Bezooijen, Juul van den Reek, Barbara Hutten, Errol Prens, Elke de Jong, Martijn van Doorn, Phyllis Spuls

Published in: Trials | Issue 1/2017

Login to get access

Excerpt

The author initials were not complete in the original publication [1]. …
Literature
1.
go back to reference Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial. Trials. 2017;18:52 doi: 10.1186/s13063-017-1777-y. Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial. Trials. 2017;18:52 doi: 10.​1186/​s13063-017-1777-y.
Metadata
Title
Erratum to: Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial
Authors
Celine Busard
Stef Menting
SJ van Bezooijen
Juul van den Reek
Barbara Hutten
Errol Prens
Elke de Jong
Martijn van Doorn
Phyllis Spuls
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Trials / Issue 1/2017
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-017-1848-0

Other articles of this Issue 1/2017

Trials 1/2017 Go to the issue